Skip to content

Evaluating the feasibility and effectiveness of internet cognitive behaviour therapy for anxiety and depression among cancer survivors

A feasibility open trial of a transdiagnostic Internet cognitive behaviour therapy (ICBT) for cancer survivors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN60887190
Enrollment
30
Registered
2014-02-27
Start date
2013-02-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder, Generalized Anxiety Disorder, Panic Disorder, Social Phobia Mental and Behavioural Disorders

Interventions

Therapist-assisted Transdiagnostic Internet-based CBT. The intervention is titled Wellbeing After Cancer, which is a transdiagnostic ICBT program designed to treat symptoms of anxiety and depression

Sponsors

University of Regina (Canada)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Resident of Saskatchewan 2. Aged 18 years or older, either sex 3. Currently experiencing clinically significant symptoms of depression, anxiety, social phobia, and/or panic 4. Has regular access to a computer, Internet, and printer 5. Comfortable using the Internet and writing e-mails 6. In remission from any stage and any type of cancer as long as at least 1 month has passed since the completion of active treatment (radiation, chemotherapy, or surgery) but no longer than 18 months 7. Willing to have their physician, a medical clinical, or an emergency hospital be notified of participation in the program

Exclusion criteria

Exclusion criteria: 1. Not a resident of Saskatchewan 2. Less than 18 years of age 3. Has no regular access to a computer, Internet, and use of printer 4. Currently receiving psychotherapeutic treatment for anxiety or depression elsewhere or in some other form 5. Started a new psychotropic medication within the past month or had a change in dosage within the past month 6. Meets criteria for current substance abuse or dependence (drugs or alcohol) 7. Meets current criteria for a psychotic disorder or bipolar disorder, or severe symptoms of depression, including frequent suicidal ideation

Design outcomes

Primary

MeasureTime frame
1. Patient Health Questionnaire ? 9 Item 2. Generalized Anxiety Disorder ? 7 Item 3. Hospital Anxiety and Depression Scale These will be administered at baseline, post-treatment, and 3-month follow-up.

Secondary

MeasureTime frame
1. Medical Outcomes Study Short Form 2. Brief Pain Inventory 3. Fatigue Symptom Inventory 4. Short Health Anxiety Inventory 5. Treatment Satisfaction Questionnaire 6. Post-Treatment Program Check-List 7. Working Alliance Inventory 8. Client Feedback Open-Ended Questions (administered via telephone interview) Most measures are administered at baseline, post-treatment, and 3-month follow-up. Some are administered exclusively at post-treatment. Some measures are administered weekly. Baseline: Patient Health Questionnaire ? 9 Item, Generalized Anxiety Disorder ? 7 Item, Hospital Anxiety and Depression Scale, Medical Outcomes Study Short Form, Brief Pain Inventory, Fatigue Symptom Inventory, Short Health Anxiety Inventory Weekly: Patient Health Questionnaire ? 9 Item, Generalized Anxiety Disorder ? 7 Item, Working Alliance Inventory (administered only at Week 5) Post-Treatment: Patient Health Questionnaire ? 9 Item, Generalized Anxiety Disorder ? 7 Item, Hospital Anxiety and Depression Scale, Medical Outcomes Study Short Form, Brief Pain Inventory, Fatigue Symptom Inventory, Short Health Anxiety Inventory, Treatment Satisfaction Questionnaire, Post-Treatment Program Check-List, Working Alliance Inventory, Client Feedback Open-Ended Questions 3-Month Follow-Up: Patient Health Questionnaire ? 9 Item, Generalized Anxiety Disorder ? 7 Item, Hospital Anxiety and Depression Scale, Medical Outcomes Study Short Form, Brief Pain Inventory, Fatigue Symptom Inventory, Short Health Anxiety Inventory

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026